Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women

Maturitas

Volumn 65, Issue 3, 2010, Pages 272-275

  Milewicz, Andrzej ^a   Jedrzejuk, Diana ^a   Dunajska, Katarzyna ^b   Lwow, Felicja ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

Adiponectin; Obesity; Postmenopausal women

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID STORAGE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; POSTMENOPAUSE; QUESTIONNAIRE; TELECONSULTATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREVALENCE; QUESTIONNAIRES; REFERENCE VALUES; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 76549112462     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.11.008     Document Type: Article

References (30)

1. Bjorntrop P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 4 (1988) 615-622
2. Hubert H.B., Fenileb M., McNamara P.M., and Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 67 (1983) 968-977
3. Welin L., Eriksson H., Larsson B., Svardsudd K., Wilhelmsen L., and Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 82 (1993) 223-228
4. Lobo R.A. Metabolic syndrome after menopause and the role of hormones. Maturitas 60 (2008) 10-18
5. Andres R. Effect of obesity on total mortality. Int J Obes 4 (1980) 381-386
6. Ruderman N.B., Schneider S.H., and Berchtold P. The "metabolically-obese" normal-weight individual. Am J Clin Nutr 34 (1981) 1617-1621
7. Ruderman N.B., Berchtold P., and Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes 6 (1982) 151-157
8. Sims E.A. Characterization of the Syndromes Of Obesity, Diabetes Mellitus And Obesity (1982), Williams & Wilkins, Baltimore, London
9. Karelis A.D., St-Pierre D.H., Conus F., Rabasa-Lhoret R., and Poehlman E.T. Metabolic and body composition factors in subgroups of obesity: what do we know?. J Clin Endocrinol Metab 89 (2004) 2569-2575
10. Berg A.H., Combs T.P., Du X., Brownlee M., and Scherer P.E. The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nat Med 8 (2001) 947-953
11. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat Med 11 (2002) 1288-1295
12. Wu X., Motoshima H., Mahadev K., Stalker T.J., Scalia R., and Goldstein B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52 (2003) 1355-1363
13. Wannamethee S.G., Lowe G.D., Rumley A., Cherry L., Whincup P.H., and Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30 (2007) 1200-1205
14. Snijder M.B., Heine R.J., Seidell J.C., et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes Care 29 (2006) 2498-2503
15. Spranger J., Kroke A., Möhlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
16. Zimmet P., Alberti G., and Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 50 (2005) 31-33
17. Shen W., Punyanitya M., Chen J., et al. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (SilverSpring) 14 (2006) 727-736
18. Greenfield J.R., Samaras K., and Chisholm D.J. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type I diabetes mellitus. J Clin Endocrinol Metab 87 (2002) 1036-1040
19. McFarlane S.I., Banerji M., and Siwers J.R. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 86 (2001) 713-718
20. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
21. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Clin Endocrinol Metab 86 (2001) 3815-3819
22. Yamamuschi T., Kamon J., Walki H., Terauchi Y., Kubota N., and Hara K. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 (2002) 941-946
23. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipemia. J Clin Endocrinol Metab 87 (2002) 2764-2769
24. Hung J., McQuillan B.M., Thompson P.L., and Beilby J.P. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes 32 (2008) 772-779
25. Tajtákova M., Petrásova D., Petrovicová J., Pytliak M., and Semanová Z. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome. Endocr Regul 40 (2006) 15-19
26. Salas-Salvadó J., Granada M., Bulló M., Corominas A., Casas P., and Foz M. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism 56 (2007) 1486-1492
27. Santaniemi M., Kesäniemi Y.A., and Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 155 (2006) 745-750
28. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., and Okamoto Y. Plasma concentrations of a novel adipose-specific protein adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2002) 1595-1599
29. Schneider J.G., von Eynatten M., Schiekofer S., Nawroth P.P., and Dugi K.A. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 28 (2005) 2181-2186
30. Wang J., Li H., Franco O.H., Yu Z., Liu Y., and Lin X. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 16 (2008) 172-178